Literature DB >> 11278954

Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51.

H J Datta1, P P Chan, K M Vasquez, R C Gupta, P M Glazer.   

Abstract

Triple helix-forming oligonucleotides (TFOs) can bind to polypurine/polypyrimidine regions in DNA in a sequence-specific manner. Triple helix formation has been shown to stimulate recombination in mammalian cells in both episomal and chromosomal targets containing direct repeat sequences. Bifunctional oligonucleotides consisting of a recombination donor domain tethered to a TFO domain were found to mediate site-specific recombination in an intracellular SV40 vector target. To elucidate the mechanism of triplex-induced recombination, we have examined the ability of intermolecular triplexes to provoke recombination within plasmid substrates in human cell-free extracts. An assay for reversion of a point mutation in the supFG1 gene in the plasmid pSupFG1/G144C was established in which recombination in the extracts was detected upon transformation into indicator bacteria. A bifunctional oligonucleotide containing a 30-nucleotide TFO domain linked to a 40-nucleotide donor domain was found to mediate gene correction in vitro at a frequency of 46 x 10(-)5, at least 20-fold above background and over 4-fold greater than the donor segment alone. Physical linkage of the TFO to the donor was unnecessary, as co-mixture of separate TFO and donor segments also yielded elevated gene correction frequencies. When the recombination and repair proteins HsRad51 and XPA were depleted from the extracts using specific antibodies, the triplex-induced recombination was diminished, but was either partially or completely restored upon supplementation with the purified HsRad51 or XPA proteins, respectively. These results establish that triplex-induced, intermolecular recombination between plasmid targets and short fragments of homologous DNA can be detected in human cell extracts and that this process is dependent on both XPA and HsRad51.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278954     DOI: 10.1074/jbc.M011646200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Site-directed recombination via bifunctional PNA-DNA conjugates.

Authors:  Faye A Rogers; Karen M Vasquez; Michael Egholm; Peter M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 2.  Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.

Authors:  Taco G Uil; Hidde J Haisma; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

Review 3.  Sequence-specific modification of genomic DNA by small DNA fragments.

Authors:  Dieter C Gruenert; Emanuela Bruscia; Giuseppe Novelli; Alessia Colosimo; Bruno Dallapiccola; Federica Sangiuolo; Kaarin K Goncz
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

4.  Intracellular generation of single-stranded DNA for chromosomal triplex formation and induced recombination.

Authors:  H J Datta; P M Glazer
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

5.  Targeted gene correction using psoralen, chlorambucil and camptothecin conjugates of triplex forming peptide nucleic acid (PNA).

Authors:  Henrik Birkedal; Peter E Nielsen
Journal:  Artif DNA PNA XNA       Date:  2011-01

6.  Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids.

Authors:  Erica B Schleifman; Ranjit Bindra; Jean Leif; Jacob del Campo; Faye A Rogers; Pradeep Uchil; Olaf Kutsch; Leonard D Shultz; Priti Kumar; Dale L Greiner; Peter M Glazer
Journal:  Chem Biol       Date:  2011-09-23

Review 7.  Repair of DNA lesions associated with triplex-forming oligonucleotides.

Authors:  Joanna Y Chin; Peter M Glazer
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

8.  Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.

Authors:  Faye A Rogers; Janice A Lloyd; Meetu Kaushik Tiwari
Journal:  Artif DNA PNA XNA       Date:  2014

9.  Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer.

Authors:  Stephen B Boulware; Laura A Christensen; Howard Thames; Lezlee Coghlan; Karen M Vasquez; Rick A Finch
Journal:  Mol Carcinog       Date:  2013-05-16       Impact factor: 4.784

10.  Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.

Authors:  Raman Bahal; Elias Quijano; Nicole A McNeer; Yanfeng Liu; Dinesh C Bhunia; Francesco Lopez-Giraldez; Rachel J Fields; William M Saltzman; Danith H Ly; Peter M Glazer
Journal:  Curr Gene Ther       Date:  2014       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.